Mcmillan Shakespeare Ltd
ASX:MMS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.2
19.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MMS
stock under the Base Case scenario is
21.66
AUD.
Compared to the current market price of 17.15 AUD,
Mcmillan Shakespeare Ltd
is
Undervalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Mcmillan Shakespeare Ltd.
| JP |
|
Recruit Holdings Co Ltd
TSE:6098
|
|
| NL |
R
|
Randstad NV
AEX:RAND
|
|
| CH |
A
|
Adecco Group AG
SIX:ADEN
|
|
| US |
R
|
Robert Half Inc
SWB:RHJ
|
|
| CN |
5
|
51job Inc
F:IWQ
|
|
| JP |
P
|
Persol Holdings Co Ltd
TSE:2181
|
|
| US |
|
Korn Ferry
NYSE:KFY
|
|
| PL |
B
|
Benefit Systems SA
WSE:BFT
|
|
| JP |
|
TechnoPro Holdings Inc
TSE:6028
|
|
| US |
|
TriNet Group Inc
NYSE:TNET
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Legislative or regulatory changes targeting salary packaging and novated leasing could drastically reduce Mcmillan Shakespeare’s core revenue streams, particularly if government policies alter fringe benefit tax treatment or restrict employee benefit programs.
A weakening economic environment and rising unemployment could hamper consumer demand for novated leasing and salary packaging services, causing volume declines and pressuring profitability in the company’s principal segments.
Intensifying competition from both established players and new fintech- or digital-based challengers may erode Mcmillan Shakespeare’s market share, while the company’s ongoing integration of acquisitions magnifies execution risk if cost synergies fail to materialize.
Mcmillan Shakespeare’s leadership position in Australia’s novated leasing and salary packaging market provides durable pricing power and customer loyalty, supporting above-average margins and consistent cash flow generation.
Ongoing diversification through strategic acquisitions and expansion into related financial services (e.g., fleet management) strengthens the company’s product offering and supports cross-selling opportunities, amplifying top-line growth.
Stable recurring revenue streams from multi-year contracts with sizable corporate and government clients underpin the company’s resilience, providing reliable cash flow to fund both organic and inorganic growth initiatives.
Revenue & Expenses Breakdown
Mcmillan Shakespeare Ltd
Balance Sheet Decomposition
Mcmillan Shakespeare Ltd
| Current Assets | 711.2m |
| Cash & Short-Term Investments | 126.3m |
| Receivables | 154.2m |
| Other Current Assets | 430.7m |
| Non-Current Assets | 768.7m |
| PP&E | 263.6m |
| Intangibles | 100.7m |
| Other Non-Current Assets | 404.4m |
| Current Liabilities | 674.8m |
| Accounts Payable | 94.2m |
| Accrued Liabilities | 406.5m |
| Other Current Liabilities | 174.1m |
| Non-Current Liabilities | 692.3m |
| Long-Term Debt | 676.1m |
| Other Non-Current Liabilities | 16.3m |
Free Cash Flow Analysis
Mcmillan Shakespeare Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Mcmillan Shakespeare Ltd
|
Revenue
|
563.5m
AUD
|
|
Operating Expenses
|
-389m
AUD
|
|
Operating Income
|
174.5m
AUD
|
|
Other Expenses
|
-79.2m
AUD
|
|
Net Income
|
95.3m
AUD
|
MMS Profitability Score
Profitability Due Diligence
Mcmillan Shakespeare Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Mcmillan Shakespeare Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
MMS Solvency Score
Solvency Due Diligence
Mcmillan Shakespeare Ltd's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Score
Mcmillan Shakespeare Ltd's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MMS Price Targets Summary
Mcmillan Shakespeare Ltd
According to Wall Street analysts, the average 1-year price target for
MMS
is 20.4 AUD
with a low forecast of 18.28 AUD and a high forecast of 22.58 AUD.
Dividends
Current shareholder yield for
MMS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MMS
stock under the Base Case scenario is
21.66
AUD.
Compared to the current market price of 17.15 AUD,
Mcmillan Shakespeare Ltd
is
Undervalued by 21%.